For RPL9 high expression, GSEA pathway scoring highlighted enrichment in Alzheimer disease, Huntington disease, oxidative phosphorylation, Parkinson disease, and ribosomes (Fig. 12C). This evidence concerns the gene RPL9 and Parkinson disease.